WeTrials
Recruiting

Phase 1, Dose Escalation, Non-Randomized, Open Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells (AMSCs) for Recurrent Glioblastoma

What is this study?

This early-stage study is testing a new treatment using special stem cells taken from body fat to fight a fast-growing brain tumor that has returned. Researchers want to see if this approach is safe, find the right dose, and check if it helps patients when standard treatments are no longer working well.

Who can participate?

You may be able to join if you are 18 or older, have been diagnosed with a specific type of aggressive brain tumor that has come back, and are scheduled to have brain surgery to remove it. You must also be well enough to care for yourself and have a tumor that can be clearly measured on scans.

What will happen?

During your scheduled brain surgery to remove the returned tumor, doctors will place the stem cells directly into the empty space left in your brain. You will also have regular check-ups, brain scans, and fluid tests to help the team monitor your recovery and safety.

Where and when?

This study is currently recruiting patients and takes place in Jacksonville, Florida, in the United States.

Key Points
  • 1Tests the safety of using fat-derived stem cells for brain tumors that have returned
  • 2Stem cells are applied directly into the surgical area during brain surgery
  • 3Currently recruiting participants in Jacksonville, Florida

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Recurrent Glioblastoma, IDH-WildtypeRecurrent Astrocytoma, IDH-Mutant, Grade 4Astrocytoma, Grade IV

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.